Search Results - "SCHNEERSON, RACHEL"
-
1
Toward a new vaccine for pertussis
Published in Proceedings of the National Academy of Sciences - PNAS (04-03-2014)“…To overcome the limitations of the current pertussis vaccines, those of limited duration of action and failure to induce direct killing of Bordetella pertussis…”
Get full text
Journal Article -
2
The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines
Published in Clinical and Vaccine Immunology (01-05-2011)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates
Published in Proceedings of the National Academy of Sciences - PNAS (12-05-2009)“…Shigellosis, an enteric disease, is on the World Health Organization's priority prevention list. In one study, the Shigella sonnei O-specific polysaccharide…”
Get full text
Journal Article -
4
A Newly Discovered Cholesteryl Galactoside from Borrelia burgdorferi
Published in Proceedings of the National Academy of Sciences - PNAS (24-06-2003)“…Two major glycolipids, which comprise ≈36% of the total lipid mass from Borrelia burgdorferi, the etiological agent of Lyme disease, were investigated. We…”
Get full text
Journal Article -
5
Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice
Published in Proceedings of the National Academy of Sciences - PNAS (04-09-2007)“…Endemic and epidemic shigellosis, an acute invasive disease of the lower intestines, afflicts millions of people worldwide with an estimated one million…”
Get full text
Journal Article -
6
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
Published in Vaccine (19-10-2009)“…Abstract Production of influenza vaccines requires a minimum of 6 months after the circulating strain is isolated and the use of infectious viruses. The…”
Get full text
Journal Article -
7
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2
Published in Proceedings of the National Academy of Sciences - PNAS (01-11-2011)“…We reviewed the literature that is the basis for our proposal that (2→8)-α-Neu5Ac conjugates will be safe and effective vaccines for Group B meningococci…”
Get full text
Journal Article -
8
Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine
Published in Proceedings of the National Academy of Sciences - PNAS (08-03-2011)“…Pertussis is a highly contagious respiratory disease that is especially dangerous for infants and children. Despite mass vaccination, reported pertussis cases…”
Get full text
Journal Article -
9
Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease
Published in Carbohydrate research (06-09-2011)“…Borrelia burgdorferi is the etiological agent for Lyme disease (LD), the most common vector borne disease in the United States. There is no human vaccine…”
Get full text
Journal Article -
10
Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25
Published in Proceedings of the National Academy of Sciences - PNAS (02-01-2007)“…Malaria is a leading cause of morbidity and mortality, estimated to cause >1 million childhood deaths annually. Plasmodium falciparum causes the most severe…”
Get full text
Journal Article -
11
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule
Published in Proceedings of the National Academy of Sciences - PNAS (11-01-2011)“…One of the two essential virulence factors of Bacillus anthracis is the poly-γ-D-glutamic acid (γDPGA) capsule. Five γDPGA-specific antibody antigen-binding…”
Get full text
Journal Article -
12
Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis
Published in Clinical and Vaccine Immunology (01-02-2012)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
13
bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates
Published in Proceedings of the National Academy of Sciences - PNAS (19-01-2010)“…There is yet no licensed vaccine against malaria, a serious human disease affecting mostly children, with an annual death rate of about one million. Plasmodia,…”
Get full text
Journal Article -
14
Poly(γ-D-Glutamic Acid) Protein Conjugates Induce IgG Antibodies in Mice to the Capsule of Bacillus anthracis: A Potential Addition to the Anthrax Vaccine
Published in Proceedings of the National Academy of Sciences - PNAS (22-07-2003)“…Both the protective antigen (PA) and the poly(γ-D-glutamic acid) capsule (γDPGA) are essential for the virulence of Bacillus anthracis. A critical level of…”
Get full text
Journal Article -
15
Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children
Published in The New England journal of medicine (02-10-2003)“…To the Editor: The limitations of the three licensed typhoid vaccines that precluded their use in children younger than five years old have been overcome by a…”
Get full text
Journal Article -
16
Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component
Published in Proceedings of the National Academy of Sciences - PNAS (24-06-2008)“…Bacillus anthracis is a spore-forming bacterium that causes anthrax in humans and in other mammals. The glycoprotein BclA (Bacillus collagen-like protein of…”
Get full text
Journal Article -
17
Protein Conjugates of Synthetic Saccharides Elicit Higher Levels of Serum IgG Lipopolysaccharide Antibodies in Mice than Do Those of the O-Specific Polysaccharide from Shigella dysenteriae Type 1
Published in Proceedings of the National Academy of Sciences - PNAS (27-04-1999)“…Our development of vaccines to prevent shigellosis is based on the hypothesis that a critical (protective) level of serum IgG to the O-specific polysaccharide…”
Get full text
Journal Article -
18
The structure of the Escherichia coli O148 lipopolysaccharide core region and its linkage to the O-specific polysaccharide
Published in Carbohydrate research (03-01-2011)“…Recently it was demonstrated that Shigella dysenteriae type 1, a cause of severe dysentery epidemics, gained its O-specific polysaccharide (O-SP) from…”
Get full text
Journal Article -
19
Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-γ-D-Glutamic Acid-Protein Conjugates
Published in Infection and Immunity (01-08-2006)“…The capsule of Bacillus anthracis, composed of poly-γ-D-glutamic acid (γDPGA), is an essential virulence factor of B. anthracis. The capsule inhibits innate…”
Get full text
Journal Article -
20
Evaluation of Serum Bactericidal Antibody Assays for Haemophilus influenzae Serotype a
Published in Clinical and Vaccine Immunology (01-02-2011)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article